David Dacal-Rivas

6PUBLICATIONS
9CO-AUTHORS
Respiratory diseasesAllergyCross-sectional analysisGene and molecular therapyPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 05, 2024
Impact of comorbidities on the achievement of specific therapeutic goals in biologic-treated asthma patients.

Luis Pérez de Llano, Isabel Urrutia, Borja G Cosío

|Mar 03, 2023
Factors associated with suboptimal response to monoclonal antibodies in severe asthma.

Luis Pérez de Llano, Nuria Marina Malanda, Isabel Urrutia

|Sep 06, 2022
Trajectories of Severe Exacerbations of Chronic Obstructive Pulmonary Disease and Their Relationship with Mortality Risk.

Rafael Golpe, Juan Marco Figueira-Gonçalves, Carlos Antonio Amado-Diago

|Mar 25, 2022
The Response to Biologics is Better in Patients with Severe Asthma Than in Patients with Asthma-COPD Overlap Syndrome.

Luis Pérez de Llano, David Dacal Rivas, Nuria Marina Malanda

|Mar 19, 2021
Phenotype-Guided Asthma Therapy: An Alternative Approach to Guidelines.

Luis Pérez de Llano, David Dacal Rivas, Nagore Blanco Cid

|Aug 22, 2020
Regarding the role of F ENO in predicting failure after ICS reduction in mild-to-moderate asthma patients.

Luis Pérez de Llano, Nagore Blanco Cid, Irene Martin Robles

Pageof 1